Therapeutic Hypothermia for Cardiac Arrest
Study Summary
This trial is testing if longer periods of induced hypothermia are better for patients' neurological outcomes after cardiac arrest, in order to identify the optimal duration of induced hypothermia.
- Cardiac Arrest
- Hypoxic-Ischemic Brain Injury
- Hypothermia
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 295 Patients • NCT00878644Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
What is the population size of this research endeavor?
"Affirmative. According to the information provided on clinicaltrials.gov, this research endeavour is still searching for participants. It was initially posted in May of 2020 and amended most recently in November 2022; it seeks 1800 individuals from 67 different locations."
In what proportion of healthcare facilities is this experiment being conducted?
"This research initiative is actively recruiting patients from OSU Wexner Medical Center in Columbus, Ohio, Mercy St. Vincent Medical Center in Toledo, California and Ronald Regan UCLA Medical Center Los Angeles, Georgia alongside 67 other sites."
Are there vacancies for enrolment in this experiment?
"As per the information hosted on clinicaltrials.gov, this medical study is currently taking in participants. The trial was inaugurated on May 18th 2020 and recently updated November 22nd 2022."